BioCentury | Jun 11, 2015
Translation in Brief

Drop everything

Two groups at Harvard University have independently developed large-scale methods for analyzing gene expression characteristics of cells at a single-cell level, feeding a growing interest in cell biology for combining micro-scale detail with macro-scale throughput....
BioCentury | Nov 14, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Deep vein thrombosis (DVT); venous thromboembolism (VE) Thrombin (factor IIa; F2) In vitro and mouse studies identified a nonpeptide thrombin inhibitor that could be...
BioCentury | Feb 19, 2009
Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Thrombosis Factor Xa (F10) An SAR identified dual inhibitors of F10 and platelet aggregation that could be useful for...
BioCentury | Jan 8, 2009
Targets & Mechanisms

Gazing deeper into cancer

Three recent genomic studies in glioblastoma multiforme, 1 acute myeloid leukemia 2 and lung adenocarcinoma 3 reveal potential new drug targets and provide a next step toward personalized, whole genome-based cancer diagnostics. Genomic sequencing could...
Items per page:
1 - 4 of 4